An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM)

Columbia University Medical Center, New York

UPMC Cardiovascular Institute, Pittsburgh

Veterans Administration Healthcare System, Pittsburgh

Temple University, Philadelphia

Emory University Hospital, Atlanta

Georgia Regents University, Augusta

Cardiology Research Associates, Daytona Beach

Mayo Clinic Florida (Jacksonville), Jacksonville

University of Florida - Division of Cardiology, Gainesville

University of Miami - Miller School of Medicine, Miami

Cardiology, P.C. & Center for Therapeutic Angiogenesis, Birmingham

University of Alabama at Birmingham, Birmingham

Stern Cardiovascular Foundation, Inc., Germantown

University Hospitals - Case Medical Center, Cleveland

The Carl and Edyth Linder Center for Research & Education at The Christ Hospital, Cincinnati

Michigan CardioVascular Institute, Saginaw

University of Wisconsin-Madison Cardiovascular Medicine, Madison

Mayo Clinic, Rochester

Rush University Medical Center, Chicago

Ochsner Clinic Foundation, New Orleans

Soltero Cardiovascular Research Center, Dallas

Methodist DeBakey Heart and Vascular Center, Houston

University of Utah Health Services Center, Salt Lake City

Mayo Clinic Arizona, Phoenix

Mercy Gilbert Medical Center, Gilbert

Cedars-Sinai Heart and Lung Institute, Los Angeles

University of California Los Angeles (UCLA), Los Angeles

Scripps Clinic, La Jolla

UCSD Medical Center, La Jolla

St. John's Regional Medical Center, Oxnard

Stanford University, Stanford

Swedish Medical Center - Cherry Hill Professional Building, Seattle

Massachusetts General Hospital, Division of Cardiology, Boston

Newark Beth Israel Hospital, Newark

University of Alberta Hospital, Edmonton

Montreal Heart Institute, Montreal